KERTYOL PSO

Rebalancing treatment shampoo

Unique combination of active ingredients

KERTYOL PSO

Rebalancing treatment shampoo

Promotes the elimination of plaques - Soothes itchiness*

A supportive treatment for psoriasis-prone scalps.

  • CELASTROL : Patented** biotechnological process
  • Unique combination of active ingredients
Tube
Usable by

Teenagers - Adults

Age

From 12 year(s)

Suitable

Hair - scalp

Type of hair

All hair types - Psoriatic-prone scalp

Need

Soothe itchiness - Anti-flake

Made in France

KERTYOL P.S.O. Rebalancing treatment shampoo helps remove dry plaques and soothe itching* on psoriasis-prone scalps.
Use it three times a week for four weeks as soon as the plaques appear.
As a maintenance treatment, use it once a week to limit the recurrence of dry and thick plaques of dandruff.
A treatment that respects colour-treated hair and makes styling easier.

Benefit

77%¹ less itching* from the first applications

Benefits

• SOOTHES itching* in psoriasis-prone scalps
• HELPS remove dry plaques visible on the scalp
• LIMITS recurrence of dry plaques on the scalp through maintenance use

*Caused by skin dryness

*Caused by skin dryness
**Patent registered

Environmental impact

GMPF_GREEN-IMPACT-INDEX_Formule_Logo

Formula

Biodegradable formula*
*According to a OECD 301 test or biodegradability index method

GMPF_GREEN-IMPACT-INDEX_Emballage_Logo

Packaging

Packaging containing at least 16% recycled materials
Fully recyclable packaging
Lightweight Packaging

GMPF_GREEN-IMPACT-INDEX_Fabrication_logo

Manufacturing

Manufactured and packaged in an environmentally certified facility****
****According to ISO 14001 and/or 50001

Societal impact

GMPF_GREEN-IMPACT-INDEX_RSE_Logo

Product manufactured and packaged in a factory with high social standards
Ducray is a brand of the Pierre Fabre Group, certified at the highest Exemplary level of AFNOR Certification’s Committed to CSR and Responsibility Europe labels, thus consolidating a long-standing commitment to contributing to sustainable development.
Does not contain animal raw materials

The Green Impact Index is a tool displaying the environmental and societal impact of cosmetics, dietary supplements and wellness and family health products, based on the methodology of the AFNOR Spec 2215. Developed thanks to the contribution of 22 companies, associations and federations, it assesses your products on more than 50 criteria for ever greater transparency!

Understanding the Green Impact Index

Application

Frequency of use

3 times a week for 4 weeks

• Apply to damp hair
• Massage gently and rinse off
• Reapply, leave for 2 to 3 minutes and then rinse thoroughly
• In the attack phase : 3 shampoos per week for 4 weeks
• In the maintenance phase : 1 shampoo per week, alternating with the gentle shampoo
Precaution to use :
• Avoid contact with eyes ; in case of contact with eyes, rinse thoroughly with water

Ingredients

WATER (AQUA). COCOS NUCIFERA (COCONUT) OIL (COCOS NUCIFERA OIL). SODIUM TRIDECETH SULFATE. SODIUM LAUROAMPHOACETATE. COCAMIDE MIPA. GLYCERIN. SODIUM CHLORIDE. SALICYLIC ACID. 1,2-HEXANEDIOL. CAPRYLYL GLYCOL. CICHORIUM INTYBUS (CHICORY) ROOT EXTRACT. FRAGRANCE (PARFUM). ICTASOL. PENTYLENE GLYCOL. TRIPTERYGIUM WILFORDII CALLUS EXTRACT

The consumer is advised to systematically check the composition of the product before purchasing it.

VEDERINE™

VEDERINE™?

Active ingredient that promotes cell differentiation so plaques are more easily removed from the skin.
Celastrol

Celastrol

1st innovative active ingredient from Pierre Fabre biotechnology, Celastrol, is of 100% natural origin and produced through the cultivation of plant cells. This soothing active ingredient directly targets keratinocytes to reduce the appearance of plaques and improve skin appearance

Results

• -77% of the itching from the first applications¹
• -78% of the thickness of the plaques from 1 month²
• +79% improved quality of life after 1 month³

    ¹²³Clinical study of 54 subjects with mild to moderate psoriasis on the scalp. 4-week attack phase : 3 shampoos per week.
    ¹Evaluation of the intensity of the itching by the subject at T8 days.
    ²Clinical evaluation of the thickness of the plaques at T29 days.
    ³Perceived evaluation of the improvement in quality of life at 29 days.

    In the same range

      Loading...